AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: Thomas C. Palmer Jr.
Aug. 1--Biotech pioneer Genzyme Corp. is moving one of its three divisions into the former Lotus Development building, 55 Cambridge Parkway, only a few blocks from where the company's world headquarters is under construction.
Top officials at Genzyme, currently located at One Kendall Square, and Cabot, Cabot & Forbes of New England Inc., developer and owner of 55 Cambridge Parkway, said yesterday that the company has signed a seven-year lease for 61,101 square feet of space.
Genzyme spokesman Bo Piela said the 21-year-old company will make the former Lotus building headquarters for the 200 employees in its biosurgery division.
"It is close to where we are now and also very close to where our new corporate headquarters will be," said Piela. Genzyme's company headquarters is expected to shift to a new 285,000-square-foot Lyme Properties building at Binney and Third streets in a little over a year.
The biosurgery unit, which will occupy floors three through six on one wing of the T-shaped ex-Lotus building beginning in November, focuses on developing products for diseases that are treated by surgeons.
For example, Genzyme is working on gene therapy to improve the outcome of heart surgery by growing blood vessels or replacing damaged tissue.